Background and Purpose-Thrombolysis rates among minor stroke (MS) patients are increasing because of increased recognition of disability in this group and guideline changes regarding treatment indications. We examined the association of delays in door-to-needle (DTN) time with stroke severity. Methods-We performed a retrospective analysis of all stroke patients who received intravenous tissue-type plasminogen activator in our emergency department between July 1, 2011, and February 29, 2016. Baseline characteristics and DTN were compared between MS (National Institutes of Health Stroke Scale score ≤5) and nonminor strokes (National Institutes of Health Stroke Scale score >5). We applied causal inference methodology to estimate the magnitude and mechanisms of the causal effect of stroke severity on DTN. 
R
ates of thrombolysis for patients with minor strokes (MS; National Institutes of Health Stroke Scale [NIHSS] score ≤5) have historically lagged behind those with nonminor deficits. Few MS patients were included in the efficacy trials of intravenous tissue-type plasminogen activator (IV-tPA), 1 and minor symptoms were previously a relative contraindication to thrombolysis. 2 Emerging recognition of both disability 3 and thrombolysis safety 4 has led to increased thrombolysis of MS patients. 5 A continued rise is expected as treatment guidelines change. 2 Evolving practice patterns make identifying opportunities to expedite MS treatment essential.
In this cohort study, we compare treatment times between MS and nonminor stroke (NMS) patients and use standard methods of causal inference to evaluate mechanisms through which MS cause prolonged door-to-needle (DTN) times.
Methods
We queried our prospective stroke registry for patients who received IV-tPA in our emergency department from July 1, 2011, to February 29, 2016. MS was defined as NIHSS score ≤5. 1 We compared demographics, emergency medical services (EMS) usage and prenotification, DTN, and component times between MS and NMS (NIHSS score >5) patients. We also compared the proportion of MS and NMS patients with the fastest DTN (lowest quartile, ≤45 minutes). All times were abstracted from a standardized stroke consult note in the electronic medical record modeled on Get-With-The-Guidelines requirements. Categorical variables were compared with χ 2 , continuous with Student t, and medians with Mann-Whitney U tests.
We applied standard methods of causal inference 6 to estimate the magnitude and mechanisms of the effect of stroke severity on DTN. In particular, we explored emergency department mode of arrival (MOA) as a mediator. MOA took 3 values: walk-in, EMS without prenotification, and EMS prenotification. We estimated the (1) average effect of stroke severity on DTN, (2) average effect of stroke severity on MOA, (3) average effect of MOA on DTN, (4) conditional average effects of MOA on DTN in MS and NMS, and (5) controlled direct effects 7 (CDEs) of stroke severity on DTN with MOA fixed. Conditional average effects are causal effects within subpopulations (ie, MS and NMS patients). CDEs are causal effects had mediators taken a fixed value in the population. For example, the CDE of stroke severity on DTN with MOA fixed at EMS prenotification is the effect of stroke severity had everybody arrived with EMS prenotification. This is a direct effect because if everybody had the same MOA, then any effect of stroke severity must be through pathways other than MOA.
We adjusted for age, sex, and primary language. The conditional expectations in the g-formula were estimated by random forest. 8 SEs were computed using nonparametric bootstrap. The Figure describes causal assumptions required to avoid confounding and selection bias. SPSS v23.0 was used for descriptive analyses; R Statistical Software for causal modeling. P<0.05 was significant. The Columbia University Medical Center Institutional Review Board approved this study.
Results
Over the study period, 372 patients received IV-tPA. Of these, 9 patients (2.4%) developed symptoms after emergency department arrival for a different cause and 48 patients (12 Table 2 summarizes causal analyses. The estimated effect of MS on DTN through all mechanisms is ≈6 minutes (95% confidence interval, 2-9 minutes). That is, with all other prestroke variables equal, average DTN would be 6 minutes longer if every stroke were minor than if every stroke were nonminor.
We also estimated that stroke severity affects prenotification, and prenotification in turn affects DTN. If all strokes were minor, the probability of EMS prenotification would be 28% versus 78% if all strokes were nonminor. If everyone received EMS prenotification, average DTN would be ≈6 minutes shorter than if everyone arrived via walk-in or EMS without prenotification. Among MS patients, we estimated that EMS prenotification reduces average DTN by ≈10 minutes (95% confidence interval, 3-17 minutes).
To evaluate whether any effect of stroke severity on DTN would remain if everyone received EMS prenotification, we estimated the CDE of MS with MOA set to EMS prenotification. Figure. A, Causal graph representing assumptions necessary to avoid bias from unobserved confounding in all our analyses. Specifically, it communicates the assumptions that there are no common causes of stroke severity and mode of arrival (MOA), stroke severity and door-to-needle (DTN), or MOA and DTN other than age, sex, and primary language. Each individual analysis requires only a subset of these assumptions. B, Causal graph that encodes the assumptions necessary to ensure that we did not induce selection bias in any of our causal analyses by restricting the sample only to patients who received IV-tPA (tissue-type plasminogen activator). Specifically, we assume that (1) there are no unobserved common causes of MOA and IV-tPA administration; (2) MOA does not influence whether IV-tPA is administered; and (3) the time until it is determined whether to administer IV-tPA does not influence whether IV-tPA is administered. 
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This CDE was 2.6 minutes, but the data were consistent with no direct effect. To assess the effect of stroke severity on DTN through other mechanisms in the absence of EMS prenotification, we considered the CDEs of stroke severity on DTN setting MOA to EMS without prenotification and walk-in. If everyone had arrived by these MOAs, MS would increase DTN by 6 minutes (95% confidence interval, 1-10 minutes).
Discussion
After observing longer DTN in MS patients, we estimated the magnitude and mechanism of the causal effect of stroke severity on DTN. We found that MOA is an important mediator. Specifically, MS decreases EMS prenotification. In turn, EMS prenotification decreases DTN, particularly in MS patients. The data were consistent with no direct effect of stroke severity on DTN if EMS prenotification were universal. Our analyses suggest that targeted interventions to increase EMS prenotification among MS patients could yield large public health benefits. Decreased prenotification among MS patients may suggest delayed stroke symptom recognition by EMS personnel. 9 Alternatively, poor recognition of minor symptoms by patients may affect EMS assessments. 10 Although national data confirm increasing odds of EMS prenotification with greater stroke severity, 11 our findings highlight the need for specific interventions among MS patients, a population often missed by current EMS screening tools. 9 Another factor in longer DTN times in MS patients may be physician uncertainty about use of IV-tPA treatment in this group. Physician comfort with treating outside guideline recommendations has been demonstrated to play a role in IV-tPA treatment, which may have affected our findings. 12 This study has several limitations. As an observational study, unobserved confounding bias is likely. Including only tPAtreated patients could introduce selection bias. Assumptions required to avoid these biases are explained in the Figure and in the online-only Data Supplement. We also were unable to account for patient location at the time of stroke, which could affect EMS usage. Finally, as a single-center study, our findings may have limited generalizability.
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